Nov 7, 2025: Metsera announced it would accept Pfizers revised bid: $86.25 per share ($65.60 cash + $20.65 CVR) ( [6] ) ( [7] )
At Digestive & Liver Disease Consultants, P.A., we specialize in diagnosing and treating liver conditions, including fatty liver disease, hepatitis, and cirrhosis
Its effects are localized, making it less effective for systemic antioxidant support but useful for addressing specific skin concerns
Gastroparesis causes persistent severe nausea, vomiting of undigested food hours after eating, early satiety, and abdominal bloating that worsens over time rather than improving
Shade developed our Liposomal Glutathione
NAD+ and Sermorelin are available only following medical evaluation by a licensed healthcare provider